Hydroxychloroquine for chronic myeloid leukemia: Complete cure on the horizon?

Expert Review of Hematology

Volumn 4, Issue 4, 2011, Pages 369-371

  Mukhopadhyay, Arunima ^a   Helgason, Gudmundur V ^a   Karvela, Maria ^a   Holyoake, Tessa L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

autophagy; chronic myeloid leukemia; driver; hydroxychloroquine; tyrosine kinase inhibitor

Indexed keywords

BCR ABL PROTEIN; CHLOROQUINE; DANUSERTIB; DASATINIB; HYDROXYCHLOROQUINE; IMATINIB; NILOTINIB; PONATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

AUTOPHAGY; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79961064452     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.11.34     Document Type: Review

References (19)

1. + cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity. Proc. Natl Acad. Sci. USA 97(19), 10538-10543 (2000).
2. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328(6128), 342-344 (1987). (Pubitemid 17097654)
3. Druker BJ. Perspectives on the development of a molecularly targeted agent. Cancer Cell 1(1), 31-36 (2002). (Pubitemid 41039173)
4. Naka K, Hoshii T, Muraguchi T et al. TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463(7281), 676-680 (2010).
5. Bellodi C, Lidonnici MR, Hamilton A et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119(5), 1109-1123 (2009).
6. Sharma SV, Gajowniczek P, Way IP et al. A common signaling cascade may underlie ddiction to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10(5), 425-435 (2006). (Pubitemid 44693471)
7. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23(16), 2891-2906 (2004). (Pubitemid 38638851)
8. Amaravadi RK. Autophagy-induced tumor dormancy in ovarian cancer. J. Clin. Invest. 118(12), 3837-3840 (2008).
9. Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol. Ther. 20(4), 160-174 (2007). (Pubitemid 350029307)
10. Savarino A, Lucia MB, Giordano F, Cauda R. Risks and benefits of chloroquine use in anticancer strategies. Lancet Oncol. 7(10), 792-793 (2006). (Pubitemid 44464070)
11. Boya P, Gonzalez-Polo RA, Poncet D et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22(25), 3927-3936 (2003). (Pubitemid 36819666)
12. Kim EL, Wustenberg R, Rubsam A et al. Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro. Oncol. 12(4), 389-400 (2010).
13. Zaidi AU, McDonough JS, Klocke BJ et al. Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent βut caspase-independent. J. Neuropathol. Exp. Neurol. 60(10), 937-945 (2001). (Pubitemid 32924119)
14. Ozvegy-Laczka C, Cserepes J, Elkind NB, Sarkadi B. Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters. Drug Resist. Updat. 8(1-2), 15-26 (2005). (Pubitemid 40797953)
15. Furst DE, Lindsley H, Baethge B et al. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis Rheum. 42(2), 357-365 (1999). (Pubitemid 29072854)
16. Munster T, Gibbs JP, Shen D et al. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum. 46(6), 1460-1469 (2002). (Pubitemid 34620191)
17. Belloni D, Veschini L, Foglieni C et al. Bortezomib induces autophagic death in proliferating human endothelial cells. Exp. Cell Res. 316(6), 1010-1018 (2010).
18. Zhang N, Qi Y, Wadham C et al. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy 6(8), 1157-1167 (2010).
19. Pan J, Chen B, Su CH et al. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol. Ther. 7(10), 1679-1684 (2008).